The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of next-generation sequencing (NGS) on diagnostic and therapeutic options in soft-tissue and bone sarcoma.
 
Mrinal M. Gounder
Honoraria - Amgen; Daiichi Sankyo; Karyopharm Therapeutics; TRACON Pharma
Consulting or Advisory Role - Amgen; Daiichi Sankyo; Epizyme; Karyopharm Therapeutics
Speakers' Bureau - Amgen
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo; Karyopharm Therapeutics
 
Siraj Mahamed Ali
Employment - Foundation Medicine
Leadership - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Victoria Robinson
No Relationships to Disclose
 
Mark Bailey
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Richard Ferraro
No Relationships to Disclose
 
Nirali M Patel
No Relationships to Disclose
 
Anita Krishnan
No Relationships to Disclose
 
Sherri Z. Millis
Employment - Foundation Medicine
 
Mark Andrew Dickson
No Relationships to Disclose
 
Sandra P. D'Angelo
Consulting or Advisory Role - Amgen; EMD Serono; Nektar
 
Mary Louise Keohan
No Relationships to Disclose
 
Vincent A. Miller
Employment - Foundation Medicine
Leadership - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Gary K. Schwartz
Honoraria - BioMotiv; Bionaut Labs; Champions Oncology; Daiichi Sankyo; DarwinHealth; Human Longevity, Inc; Karyopharm Therapeutics
Consulting or Advisory Role - BioMotiv; Bionaut Labs; Champions Oncology; Daiichi Sankyo; DarwinHealth; Human Longevity, Inc; Karyopharm Therapeutics; PureTech
Research Funding - Astex Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Patent pending regarding development of PNAs for targeted cancer therapy (new technology)
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Robert G. Maki
Honoraria - Lilly
Consulting or Advisory Role - AADi; Arcus Ventures; Bayer; Eisai; Gem Pharmaceuticals; Immune Design; Karyopharm Therapeutics; Lilly/ImClone; Presage Biosciences; SARC: Sarcoma Alliance for Research though Collaboration; TRACON Pharma
Research Funding - Immune Design (Inst); Lilly (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Uptodate: I write and edit chapters for their online text book.
Travel, Accommodations, Expenses - Bayer/Onyx; Immune Design; TRACON Pharma
 
William D. Tap
Consulting or Advisory Role - Adaptimmune; Daiichi Sankyo; Eisai; EMD Serono; Immune Design; Janssen; Lilly; Novartis; Plexxikon; TRACON Pharma